NCT07295288
Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial Synkinesis
StatusWithdrawn
PhasePhase 4
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Stopped Withdrawn before enrolling Sponsor's reason: Unable to secure funding for TMJ and masseter Botox.
- Enrollment target: estimated 50 to confirmed 0
- Eligibility criteria expanded, about 8 words
- Notable Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2027
- Start date: Feb 1, 2026 to Jul 1, 2026
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Synkinesis Assessment Questionnaire (SAQ)
Timeframe: Pre-treatment and repeated 5 weeks post-treatment
Headache Impact Test (HIT-6)
Timeframe: Pre-treatment and repeated 5 weeks post-treatment
Temporomandibular Disorder Questionnare (TMD-7)
Timeframe: Pre-treatment and repeated 5 weeks post-treatment
Arms and interventions
Even MRNOther
Patients with MRNs ending in an even number will undergo their standard BT injections (CN7 muscle groups only) + non-CN7 muscle groups at their first treatment session, followed by standard BT injections alone at their second treatment session.
Odd MRNOther
Patients with MRNs that end in an odd number will undergo the reverse injection process (standard BT injections alone at first treatment session, followed by standard BT injections + non-CN7 muscle groups at their second treatment session).
Drugs: Botulinum Toxin Type A Injection [Botox]